Immunogenicity 15808

summary
Sample ID
patient19
Response
Positive
Tumor Type
Melanoma
Gene Symbol
SLC16A4
Transcript ID
None
HLA INFO
A*11:01
TCR INFO

No TCR info found!

T cell Tumor cell A*11:01
sequence
Full length protein sequence (487 aa)
MLKRE
1
GKVQP
6
YTKTL
11
DGGWG
16
WMIVI
21
HFFLV
26
NVFVM
31
GMTKT
36
FAIFF
41
VVFQE
46
EFEGT
51
SEQIG
56
WIGSI
61
MSSLR
66
FCAGP
71
LVAII
76
CDILG
81
EKTTS
86
ILGAF
91
VVTGG
96
YLISS
101
WATSI
106
PFLCV
111
TMGLL
116
PGLGS
121
AFLYQ
126
VAAVV
131
TTKYF
136
KKRLA
141
LSTAI
146
ARSGM
151
GLTFL
156
LAPFT
161
KFLID
166
LYDWT
171
GALIL
176
FGAIA
181
LNLVP
186
SSMLL
191
RPIHI
196
KSENN
201
SGIKD
206
KGSSL
211
SAHGP
216
EAHAT
221
ETHCH
226
ETEES
231
TIKDS
236
TTQKA
241
GLPSK
246
NLTVS
251
QNQSE
256
EFYNG
261
PNRNR
266
LLLKS
271
DEESD
276
KVISW
281
SCKQL
286
FDISL
291
FRNPF
296
FYIFT
301
WSFLL
306
SQLAY
311
FIPTF
316
HLVAR
321
AKTLG
326
IDIMD
331
ASYLV
336
SVAGI
341
LETVS
346
QIISG
351
WVADQ
356
NWIKK
361
YHYHK
366
SYLIL
371
CGITN
376
LLAPL
381
ATTFP
386
LLMTY
391
TICFA
396
IFAGG
401
YLALI
406
LPVLV
411
DLCRN
416
STVNR
421
FLGLA
426
SFFAG
431
MAVLS
436
GPPIA
441
GWLYD
446
YTQTY
451
NGSFY
456
FSGIC
461
YLLSS
466
VSFFF
471
VPLAE
476
RWKNS
481
LT
486
Mutation Information
DNA mutation:
None
Peptide Range:
468 ~ 476
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"LSSVSFFFV
|||||||.|
Mutant:
LSSVSFFLV"
reference
clinic trial
Checkpoint Blockade

pembrolizumab

ACT

N

Vaccination

N

Curative Effect

no recurrence

experiment
minimal_peptide

Y

Antigen Type

multimer

T-cell Source

PBMCs

APC Type

None

Assay

None